Charles River Laboratories (CRL) Tops Q2 EPS by 5c, beats revenue, offers guidance
Go back to Charles River Laboratories (CRL) Tops Q2 EPS by 5c, beats revenue, offers guidance| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 188.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $188.06 | 52 Week High | $89.18 | |||
| Open | $188.06 | 52 Week Low | $65.70 | |||
| Day High | $188.06 | P/E | 87.47 | |||
| Day Low | $188.06 | EPS | $2.15 | |||
| Volume | 22 | |||||
